Evidence map›Paper›PMID 38910242›Full record

Observational studyBMC infectious diseases2024

Mortality in clostridioides difficile infection among patients hospitalized at the university clinical hospital in Wroclaw, Poland - a 3-year observational study.

Jarosław Drobnik, Piotr Pobrotyn, Mária Belovičová, Katarzyna Madziarska, Małgorzata Trocha, Mateusz Baran

Abstract readObservational Study
In one paragraph

Observational study in BMC infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trends and Efficacy in Clostridioides difficile Infection Management at a Polish Clinical Hospital.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Article
  2. Medicina (Kaunas, Lithuania) · 2025
    Article
  3. The Global Burden ofInfectious disease reports · 2025
    Review
  4. Article
  5. Nonthyroidal Illness Syndrome inJournal of global infectious diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jarosław DrobnikDepartment of Family Medicine, Wroclaw Medical University, Wrocław, Poland.ORCID http://orcid.org/0000-0001-5472-1485
Piotr PobrotynPULSANTIS Specialist and Rehabilitation Clinic Ltd, Ostrowskiego 3, Wrocław, 53-238, Poland. pobrotynp@gmail.com.ORCID http://orcid.org/0000-0001-9216-451X
Mária BelovičováFaculty of Public Health Studies, Department of Preventive and Clinical Medicine, Slovak Medical University, Bratislava, Slovakia.ORCID http://orcid.org/0000-0001-7397-6133
Katarzyna MadziarskaClinical Department of Diabetology and Internal Diseases, Wroclaw Medical University, Wroclaw, Poland.ORCID http://orcid.org/0000-0002-3624-3691
Małgorzata TrochaClinical Department of Diabetology and Internal Diseases, Wroclaw Medical University, Wroclaw, Poland.ORCID http://orcid.org/0000-0002-3951-205X
Mateusz BaranIndividual Specialist Medical Practice, Wroclaw, Poland.ORCID http://orcid.org/0000-0002-3652-6309

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the last two decades, a significant increase in the number of Clostridioides difficile infection (CDI) cases has been observed. It is understandable to attempt to determine the factors that can predict the severity of the course of the infection and identify patients at risk of death. This study aimed to analyze the factors affecting the incidence and mortality of CDI in inpatient treatment at the University Clinical Hospital in Wrocław in 2016-2018.

methodsStatistical analysis of data obtained from patients' medical records was performed. Only patients with symptoms of infection and infection confirmed by laboratory tests were enrolled in the study. When analyzing the number of deaths, only adult patients who died in hospital wards were included. The quantitative data including laboratory tests, used antibiotics and Nutritional Risk Screening (NRS) were assessed. Also, the qualitative data such as sex, year of hospitalization, occurrence of diarrhoea on admission to the hospital, presence of additional diseases, as wee ad the use of antibacterial drugs or proton pump blockers and ranitidine during hospitalization were analyzed.

resultsA total of 319 adult CDI patients (178 women and 141 men) were enrolled of which 80 people died (50 women and 30 men). The mean age of the patients was 72.08 ± 16.74 years. Over the entire period studied, the morbidity was 174 cases per 100,000 hospitalizations while mortality was 25.08%. The group of deceased patients was characterized by: older age (by 9.24 years), longer duration of hospitalization (by 10 days), reduced albumin levels (Rho = -0.235, p < 0.001), higher urea levels, use of more antibiotics, higher risk of malnutrition in NRS (Rho = 0.219, p < 0.001), higher incidence of sepsis, heart failure, stroke, hypothyroidism. Pneumonia was diagnosed twice as often. It was also shown that deceased patients were significantly more likely to take penicillin and fluoroquinolones.

conclusionsIn this study, the morbidity was lower, but mortality was higher compared to similar hospitals in Poland. CDI patients were characterized by older age, multimorbidity, extended hospitalization, and the use of broad-spectrum antibiotics. Risk factors for death included advanced age, prolonged hospital stays, lower albumin, higher urea, malnutrition, and comorbidities like heart failure, stroke, pneumonia, sepsis, and hypothyroidism. Increased antibiotic use, particularly penicillin and fluoroquinolones, was associated with a higher mortality risk.

Indexed as

Clostridioides difficileClostridium InfectionsHospitalizationHospitals, UniversityAdultAgedAged, 80 and overAnti-Bacterial AgentsFemaleHumansIncidenceMaleMiddle AgedPolandRisk FactorsAnti-Bacterial AgentsClostridioides difficile infectionComorbiditiesHospitalizationMalnutritionMortality risk

Identifiers

PMID38910242
PMCPMC11194962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.